JPMorgan Chase & Co. Acquires 111,485 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS)
JPMorgan Chase & Co. lifted its holdings in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) by 141.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 190,457 shares of the biopharmaceutical company’s stock after acquiring an additional 111,485 shares […]
JPMorgan Chase & Co. lifted its holdings in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) by 141.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 190,457 shares of the biopharmaceutical company’s stock after acquiring an additional 111,485 shares […]
